Skip to main content

CORRECTION article

Front. Oncol., 05 May 2020
Sec. Cancer Molecular Targets and Therapeutics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.00701

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC

This article is a correction to:

  1. Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC

    1. Read original article
\nMubalake AbudoureyimuMubalake Abudoureyimu1Yongting LaiYongting Lai2Chuan TianChuan Tian1Ting WangTing Wang3Rui Wang Rui Wang1*Xiaoyuan ChuXiaoyuan Chu1
  • 1Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China
  • 2Department of Medical Oncology, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, China
  • 3Department of Medical Oncology, Jinling Hospital, Nanjing, China

A Corrigendum on
Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC

by Abudoureyimu, M., Lai, Y., Tian, C., Wang, T., Wang, R., and Chu, X. (2019). Front. Oncol. 9:1182. doi: 10.3389/fonc.2019.01182

In the original article, we neglected to include the funder the Excellent Youth Foundation of Jiangsu Province, China, BK20140032 to Rui Wang.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: gene-targeted oncolytic viral therapy, adenovirus, HCC, immunotherapy, virus engineering

Citation: Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R and Chu X (2020) Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC. Front. Oncol. 10:701. doi: 10.3389/fonc.2020.00701

Received: 13 April 2020; Accepted: 15 April 2020;
Published: 05 May 2020.

Edited and reviewed by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Abudoureyimu, Lai, Tian, Wang, Wang and Chu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Rui Wang, wangrui218@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.